142 related articles for article (PubMed ID: 22553309)
1. Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.
Roomp K; Rand J
J Feline Med Surg; 2012 Aug; 14(8):566-72. PubMed ID: 22553309
[TBL] [Abstract][Full Text] [Related]
2. Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine.
Roomp K; Rand J
J Feline Med Surg; 2009 Aug; 11(8):668-82. PubMed ID: 19592286
[TBL] [Abstract][Full Text] [Related]
3. Insulin detemir treatment in diabetic cats in a practice setting.
Hoelmkjaer KM; Spodsberg EM; Bjornvad CR
J Feline Med Surg; 2015 Feb; 17(2):144-51. PubMed ID: 24938314
[TBL] [Abstract][Full Text] [Related]
4. Management of diabetic cats with long-acting insulin.
Roomp K; Rand JS
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):251-66. PubMed ID: 23522171
[TBL] [Abstract][Full Text] [Related]
5. Feline diabetes mellitus: clinical use of long-acting glargine and detemir.
Bloom CA; Rand J
J Feline Med Surg; 2014 Mar; 16(3):205-15. PubMed ID: 24563492
[TBL] [Abstract][Full Text] [Related]
6. Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins.
Marshall RD; Rand JS; Morton JM
J Feline Med Surg; 2009 Aug; 11(8):683-91. PubMed ID: 19539509
[TBL] [Abstract][Full Text] [Related]
7. Practical use of home blood glucose monitoring in feline diabetics.
Ford SL; Lynch H
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):283-301. PubMed ID: 23522173
[TBL] [Abstract][Full Text] [Related]
8. Synthetic insulin analogs and their use in dogs and cats.
Gilor C; Graves TK
Vet Clin North Am Small Anim Pract; 2010 Mar; 40(2):297-307. PubMed ID: 20219490
[TBL] [Abstract][Full Text] [Related]
9. ISFM consensus guidelines on the practical management of diabetes mellitus in cats.
Sparkes AH; Cannon M; Church D; Fleeman L; Harvey A; Hoenig M; Peterson ME; Reusch CE; Taylor S; Rosenberg D;
J Feline Med Surg; 2015 Mar; 17(3):235-50. PubMed ID: 25701862
[TBL] [Abstract][Full Text] [Related]
10. Treatment of 46 cats with porcine lente insulin--a prospective, multicentre study.
Michiels L; Reusch CE; Boari A; Petrie G; Mandigers P; Thollot IG; Rosenberg D; Mooney C; Bonfanti U; Font A; Sparkes A; Bewig K; Clercx C; Jensen AL; Horspool LJ
J Feline Med Surg; 2008 Oct; 10(5):439-51. PubMed ID: 18619886
[TBL] [Abstract][Full Text] [Related]
11. Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins.
Arutchelvam V; Heise T; Dellweg S; Elbroend B; Minns I; Home PD
Diabet Med; 2009 Oct; 26(10):1027-32. PubMed ID: 19900235
[TBL] [Abstract][Full Text] [Related]
12. Insulin detemir: new drug. A second long-acting insulin analogue: many uncertainties, few advantages.
Prescrire Int; 2006 Oct; 15(85):163-7. PubMed ID: 17121210
[TBL] [Abstract][Full Text] [Related]
13. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
Peterson GE
Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
[TBL] [Abstract][Full Text] [Related]
14. Frequency of diabetic remission, predictors of remission and survival in cats using a low-cost, moderate-intensity, home-monitoring protocol and twice-daily glargine.
Gottlieb S; Rand JS; Anderson ST
J Feline Med Surg; 2024 Apr; 26(4):1098612X241232546. PubMed ID: 38661475
[TBL] [Abstract][Full Text] [Related]
15. The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study.
Meneghini L; Koenen C; Weng W; Selam JL
Diabetes Obes Metab; 2007 Nov; 9(6):902-13. PubMed ID: 17924873
[TBL] [Abstract][Full Text] [Related]
16. Oral hypoglycemics in cats with diabetes mellitus.
Palm CA; Feldman EC
Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):407-15. PubMed ID: 23522179
[TBL] [Abstract][Full Text] [Related]
17. Use of ultralente insulin in cats with diabetes mellitus.
Nelson RW; Feldman EC; DeVries SE
J Am Vet Med Assoc; 1992 Jun; 200(12):1828-9. PubMed ID: 1639685
[No Abstract] [Full Text] [Related]
18. Insulin detemir (levemir), a new long-acting insulin.
Med Lett Drugs Ther; 2006 Jul; 48(1238):54-5. PubMed ID: 16841022
[TBL] [Abstract][Full Text] [Related]
19. Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.
Porcellati F; Rossetti P; Busciantella NR; Marzotti S; Lucidi P; Luzio S; Owens DR; Bolli GB; Fanelli CG
Diabetes Care; 2007 Oct; 30(10):2447-52. PubMed ID: 17623819
[TBL] [Abstract][Full Text] [Related]
20. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
